Evidence map›Paper›PMID 42889717›Full record

ArticleMolecular therapy. Nucleic acids2026

DNA oligonucleotides encoding suppressor tRNA induce readthrough of premature termination codon.

Haruka Yamamoto, Peixin Zhu, Keisuke Yonehara

Abstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Haruka YamamotoDepartment of Gene Function and Phenomics, National Institute of Genetics, Mishima 411-8540, Japan.
Peixin ZhuDepartment of Gene Function and Phenomics, National Institute of Genetics, Mishima 411-8540, Japan.
Keisuke YoneharaDepartment of Gene Function and Phenomics, National Institute of Genetics, Mishima 411-8540, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonsense mutation is a type of DNA mutation that converts sense codon in mRNA into premature termination codon (PTC), causing protein truncation. Recent studies have revealed that suppressor tRNAs, which read the stop codon instead of the natural codon and encode the desired amino acid, induce PTC readthrough and restore protein function. However, RNA is prone to degradation, presenting numerous challenges for tissue delivery in gene therapy. Here, we show that DNA oligonucleotides encoding suppressor tRNA sequences but without additional Pol III promoters induce PTC readthrough in cultured cells. Sequence-matched microRNAs specifically inhibited PTC readthrough mediated by the transfected DNA oligonucleotides. Furthermore, treatment with an RNA Pol III inhibitor significantly reduced DNA oligonucleotide-mediated PTC readthrough. These findings support the conclusion that functional suppressor tRNAs are transcribed from DNA oligonucleotides in cultured cells. These results suggest that DNA oligonucleotides hold potential as a novel therapeutic approach enabling suppressor tRNA expression for nonsense mutation repair.

Indexed as

DNA oligonucleotidesMT: Oligonucleotides: Therapies and Applicationsnonsense mutationPTC readthroughsuppressor tRNAtranscription mechanism

Identifiers

PMID42889717
PMCPMC13670950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.